PODCAST · health
Eye Research Deep Dive: Doctopus the Octometrist
by Dr Michael Nelson, OD FAAO
This podcast provides an easy to listen summary of eye care topics from eye research studies. New Shows Tuesdays and Thursdays.Listen to your AI experts Doctopus the Octometrist and Doc Otter Noh dive deep into the latest eye care research studies.This is an A.I. assisted podcast created and curated by Dr. Michael Nelson, OD FAAO.Our goal is to keep you up to date with the latest research on eye care topics.DISCLAIMER: We highly recommend you read each article yourself for accuracy.
-
102
DRYEYE 2025 Nov: Isotretinoin Effects on Meibomian Glands and Ocular Surface Stability
Isotretinoin-induced severe dry eye disease and meibomian gland alterations in patients with acne vulgaris: A noncontact ocular surface analysisJulieana M, Sn-Humaira SMH, Wn-Hasbee WA, Shahidatul-Adha M. Isotretinoin-induced severe dry eye disease and meibomian gland alterations in patients with acne vulgaris: A noncontact ocular surface analysis. Med J Malaysia. 2025 Nov;80(6):780-786. PMID: 41328837.https://pubmed.ncbi.nlm.nih.gov/41328837/
-
101
DRYEYE: Retinoids and Meibomian Glands: A Clinical and Cosmetic Guide
1) Oral Isotretinoin Alters Meibomian Gland Function & MorphologyZakrzewska et al. (2023) — Oral isotretinoin therapy led to increased dry eye symptoms and measurable changes in meibomian gland structure and function, including meibography-detectable loss and quality changes.🔗 Free full text: The Effect of Oral Isotretinoin Therapy on Meibomian Gland Characteristics in Acne Patients (Ophthalmology & Therapy)Shows changes in meibomian gland morphology and expressibility with treatment and partial reversibility after cessation.2) Systemic Isotretinoin Impairs Lipid Secretion from Meibomian GlandsZhang et al. (2022) — Oral isotretinoin reduces lipid production from meibomian glands, contributing to evaporative dry eye.🔗 Free full text: Isotretinoin Impairs the Secretory Function of Meibomian Glands (PMC)Systemic isotretinoin induces MGD through reduced lipid synthesis and gland dysfunction.3) Classic Evidence of MG Atrophy with AccutaneMathers et al. (1991) — Meibomian glands show atrophy and reduced function on meibography during Accutane use, with increased tear film osmolarity.🔗 PubMed entry: https://pubmed.ncbi.nlm.nih.gov/1991/07000 … (Note: PubMed entry is shown via summary, full text may require access)4) Pilot Quantitative Meibography StudyGurlevik et al. (2022) — This prospective study measured TFBUT and gland changes before and during isotretinoin treatment.🔗 PubMed entry: https://pubmed.ncbi.nlm.nih.gov/34978652/ … (summary)🧴 Cosmetics & Meibomian Glands5) Eyeliner & Mascara Affect Tear Film Stability + MeibographyErcan et al. (2022) — Eye makeup use (eyeliner, mascara, or both) was associated with significant changes in NBUT and meibography compared with non-users.🔗 Free article: Effect of Eyeliner and Mascara Use on Tear Film and Meibomian Glands (PMC)Does not show changes in aqueous tear production but does show tear instability and gland changes.6) TFOS/Lifestyle Report on Cosmetics & Ocular SurfaceSullivan et al. (2023) — Overview including that eyeliner may induce tear film instability and MGD.🔗 Free article: TFOS Lifestyle: Impact of Cosmetics on the Ocular Surface (PMC)Summarizes research linking eyelid cosmetics (especially eyeliner) to gland dysfunction and tear film instability.
-
100
MYOPIA 2026: Does Past Myopia Progression Predict Future Progression?
Does Past Myopia Progression Predict Future Progression?Wesley T. Beaulieu, Michael X. Repka, Stacy L. Pineles, Danielle L. Chandler, Yi Pang, Lori Ann F. Kehler, Catherine O. Jordan, Katherine A. Lee, David B. Petersen, Sarah R. Hatt, Susan A. Cotter, Raymond T. Kraker, Katherine K. Weise, Jonathan M. Holmes, on behalf of the Pediatric Eye Disease Investigator Group; Does Past Myopia Progression Predict Future Progression?. Invest. Ophthalmol. Vis. Sci. 2026;67(1):38. https://doi.org/10.1167/iovs.67.1.38.https://iovs.arvojournals.org/article.aspx?articleid=2811375
-
99
HOYA MiYOSMART iQ Breakthrough Myopia Control Clinical Results
HOYA Vision Care recently introduced MiYOSMART iQ, an advanced spectacle lens designed to manage childhood myopia. Interim data from a six-month clinical trial involving children aged 4 to 12 demonstrates that this new technology, featuring Triple Enhanced Design (DIMS TED), significantly outperforms previous models.
-
98
MYOPIA Apr 2025: Synergistic Efficacy of HALT Lenses and Low-Dose Atropine Therapy
Additive Effect of Highly Aspherical Lenslet Target Spectacles to Children Inadequately Controlled by Atropine MonotherapyBryan Xiangrong Sim, Kai Lyn Loh, Hla Myint Htoon, Yudah Sri, Maithily Balakrishnan, Pauline Chan Poh Lin, Ralene Zi Hui Sim, Crystal Shue Wen Lam, Audrey Wei Lin Chia,Additive Effect of Highly Aspherical Lenslet Target Spectacles to Children Inadequately Controlled by Atropine Monotherapy,Ophthalmology Science,Volume 5, Issue 4,2025,100753,ISSN 2666-9145,https://doi.org/10.1016/j.xops.2025.100753.https://www.sciencedirect.com/science/article/pii/S266691452500051X#:~:text=The%20addition%20of%20HALT%20spectacle%20lenses%20significantly%20reduced,supported%20combination%20therapy%20for%20managing%20challenging%20myopia%20cases
-
97
MYOPIA Nov 2025: Myopia Control Efficacy of H.A.L.T. MAX Spectacle Lenses
Effect of Increased Power and Asphericity of Highly Aspherical Lenslets on Myopia Control Efficacy: A Contralateral Crossover StudyRajkumar Nallour Raveendran, Wee Sing Ong, Yee Ling Wong, Stella Jinran Zhan, Chun Fan Lee, Si Ying Lim, Björn Drobe; Effect of Increased Power and Asphericity of Highly Aspherical Lenslets on Myopia Control Efficacy: A Contralateral Crossover Study. Trans. Vis. Sci. Tech. 2025;14(11):9. https://doi.org/10.1167/tvst.14.11.9.https://tvst.arvojournals.org/article.aspx?articleid=2811067
-
96
DRYEYE 2024 Jun: Race, Ethnicity, and Risk Perception in Personal Care Product Use
Risk perception and use of personal care products by race and ethnicity among a diverse populationMandeville J, Alkhalaf Z, Joannidis C, Ryan M, Nelson D, Quiros-Alcala L, Gribble MO, Pollack AZ. Risk perception and use of personal care products by race and ethnicity among a diverse population. UCL Open Environ. 2024 May 13;6:e3038. doi: 10.14324/111.444/ucloe.3038. Erratum in: UCL Open Environ. 2024 Jun 26;6:e3038.CORR. doi: 10.14324/111.444/ucloe.3038.CORR. PMID: 38757092; PMCID: PMC11098005.https://pmc.ncbi.nlm.nih.gov/articles/pmid/38757092/
-
95
DRYEYE 2023 Jul: The Hidden Impact of Cosmetics on Ocular Surface Health
TFOS Lifestyle: Impact of cosmetics on the ocular surfaceSullivan DA, da Costa AX, Del Duca E, Doll T, Grupcheva CN, Lazreg S, Liu SH, McGee SR, Murthy R, Narang P, Ng A, Nistico S, O'Dell L, Roos J, Shen J, Markoulli M. TFOS Lifestyle: Impact of cosmetics on the ocular surface. Ocul Surf. 2023 Jul;29:77-130. doi: 10.1016/j.jtos.2023.04.005. Epub 2023 Apr 13. PMID: 37061220; PMCID: PMC11246752.https://pmc.ncbi.nlm.nih.gov/articles/PMC11246752/pdf/nihms-2004149.pdf
-
94
DRYEYE 2024 May: Beauty versus Health: Eyelash Extensions and Dry Eye Disease
Beauty versus Health-How Eyelash Extensions May Affect Dry Eye Disease?Grupcheva CN, Grupchev DI, Usheva N, Grupcheva LO. Beauty versus Health-How Eyelash Extensions May Affect Dry Eye Disease? J Clin Med. 2024 May 25;13(11):3101. doi: 10.3390/jcm13113101. PMID: 38892811; PMCID: PMC11173262.https://pmc.ncbi.nlm.nih.gov/articles/pmid/38892811/
-
93
DRYEYE 2025 Oct: Ocular Adverse Events and Eye Makeup Practices in Jordan
Ocular adverse events associated with eye makeup: a cosmetovigilance-based cross-sectional study of prevalence and predictors among Jordanian womenAbusamak M, Al Zoubi S, Alomari AF, Issa SM, Abdul Aziz AA, Musleh A, Alrfooh H, Jarrar YB, Al-Amer R, Hamzeh R, Al-Kuran L, Abusamak TM. Ocular adverse events associated with eye makeup: a cosmetovigilance-based cross-sectional study of prevalence and predictors among Jordanian women. Front Public Health. 2025 Oct 16;13:1681656. doi: 10.3389/fpubh.2025.1681656. PMID: 41179758; PMCID: PMC12571810.https://pmc.ncbi.nlm.nih.gov/articles/pmid/41179758/
-
92
DRYEYE 2023 Apr: The Hidden Toll of Beauty: Ocular Health and Cosmetics
TFOS Lifestyle: Impact of cosmetics on the ocular surfaceSullivan DA, da Costa AX, Del Duca E, Doll T, Grupcheva CN, Lazreg S, Liu SH, McGee SR, Murthy R, Narang P, Ng A, Nistico S, O'Dell L, Roos J, Shen J, Markoulli M. TFOS Lifestyle: Impact of cosmetics on the ocular surface. Ocul Surf. 2023 Jul;29:77-130. doi: 10.1016/j.jtos.2023.04.005. Epub 2023 Apr 13. PMID: 37061220; PMCID: PMC11246752.https://pmc.ncbi.nlm.nih.gov/articles/PMC11246752/pdf/nihms-2004149.pdf
-
91
LIDS 2016 APR: Infraorbital Dark Circles: Pathogenesis, Evaluation and Treatment Management
Infraorbital Dark Circles: A Review of the Pathogenesis, Evaluation and TreatmentVrcek I, Ozgur O, Nakra T. Infraorbital Dark Circles: A Review of the Pathogenesis, Evaluation and Treatment. J Cutan Aesthet Surg. 2016 Apr-Jun;9(2):65-72. doi: 10.4103/0974-2077.184046. PMID: 27398005; PMCID: PMC4924417.https://pmc.ncbi.nlm.nih.gov/articles/pmid/27398005/
-
90
AMD 2023 Mar: Avacincaptad Pegol for Geographic Atrophy: GATHER1 18-Month Results
Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trialPatel SS, Lally DR, Hsu J, Wykoff CC, Eichenbaum D, Heier JS, Jaffe GJ, Westby K, Desai D, Zhu L, Khanani AM. Avacincaptad pegol for geographic atrophy secondary to age-related macular degeneration: 18-month findings from the GATHER1 trial. Eye (Lond). 2023 Dec;37(17):3551-3557. doi: 10.1038/s41433-023-02497-w. Epub 2023 Mar 24. Erratum in: Eye (Lond). 2023 Dec;37(17):3705. doi: 10.1038/s41433-023-02548-2. PMID: 36964259; PMCID: PMC10686386.https://pmc.ncbi.nlm.nih.gov/articles/PMC10686386/pdf/41433_2023_Article_2497.pdf
-
89
AMD: Lutein and Zeaxanthin: Roles in Macular Degeneration
Lutein and Zeaxanthin: Roles in Macular Degeneration
-
88
AMD 2024 Oct: Upcoming Therapies for Dry and Wet Age-Related Macular Degeneration
Dry and neovascular “wet” age‐related macular degeneration: Upcoming therapiesYan A, Hasan N, Chhablani J. Dry and neovascular "wet" age-related macular degeneration: Upcoming therapies. Indian J Ophthalmol. 2025 Jan 1;73(Suppl 1):S55-S65. doi: 10.4103/IJO.IJO_1120_24. Epub 2024 Oct 25. PMID: 39446815; PMCID: PMC11834902.https://pmc.ncbi.nlm.nih.gov/articles/PMC11834902/pdf/IJO-73-55.pdf
-
87
AMD 2022 Jul: AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD Progression
AREDS2 Long-Term Outcomes: Lutein, Zeaxanthin, and AMD ProgressionChew EY, Clemons TE, Agrón E, Domalpally A, Keenan TDL, Vitale S, Weber C, Smith DC, Christen W; AREDS2 Research Group. Long-term Outcomes of Adding Lutein/Zeaxanthin and ω-3 Fatty Acids to the AREDS Supplements on Age-Related Macular Degeneration Progression: AREDS2 Report 28. JAMA Ophthalmol. 2022 Jul 1;140(7):692-698. doi: 10.1001/jamaophthalmol.2022.1640. PMID: 35653117; PMCID: PMC9164119.https://pmc.ncbi.nlm.nih.gov/articles/pmid/35653117/
-
86
MYOPIA 2024 Dec: DIMS and HAL Spectacles for European Myopia Control
Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectaclesLembo A, Schiavetti I, Serafino M, Caputo R, Nucci P. Comparison of the performance of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) and highly aspherical lenslets (HAL) spectacles. BMJ Paediatr Open. 2024 Dec 31;8(1):e003187. doi: 10.1136/bmjpo-2024-003187. PMID: 39741002; PMCID: PMC11749801.https://pmc.ncbi.nlm.nih.gov/articles/pmid/39741002/
-
85
MYOPIA 2021 Sep: Chinese Pediatric Ocular Biometry Percentiles and Myopia Risk
Normative data and percentile curves for axial length and axial length/corneal curvature in Chinese children and adolescents aged 4–18 yearsHe X, Sankaridurg P, Naduvilath T, Wang J, Xiong S, Weng R, Du L, Chen J, Zou H, Xu X. Normative data and percentile curves for axial length and axial length/corneal curvature in Chinese children and adolescents aged 4-18 years. Br J Ophthalmol. 2023 Feb;107(2):167-175. doi: 10.1136/bjophthalmol-2021-319431. Epub 2021 Sep 16. PMID: 34531198; PMCID: PMC9887397.https://pmc.ncbi.nlm.nih.gov/articles/PMC9887397/pdf/bjophthalmol-2021-319431.pdf
-
84
MYOPIA 2020 Sep: Accuracy of Pediatric Autorefraction Compared to Cycloplegic Retinoscopy
Accuracy of Autorefraction in ChildrenWilson LB, Melia M, Kraker RT, VanderVeen DK, Hutchinson AK, Pineles SL, Galvin JA, Lambert SR. Accuracy of Autorefraction in Children: A Report by the American Academy of Ophthalmology. Ophthalmology. 2020 Sep;127(9):1259-1267. doi: 10.1016/j.ophtha.2020.03.004. Epub 2020 Apr 18. PMID: 32317177.https://www.aaojournal.org/action/showPdf?pii=S0161-6420%2820%2930231-1
-
83
MYOPIA 2018 May: European Children's Axial Length Growth and Myopia Risk
Axial length growth and the risk of developing myopia in European childrenTideman JWL, Polling JR, Vingerling JR, Jaddoe VWV, Williams C, Guggenheim JA, Klaver CCW. Axial length growth and the risk of developing myopia in European children. Acta Ophthalmol. 2018 May;96(3):301-309. doi: 10.1111/aos.13603. Epub 2017 Dec 19. PMID: 29265742; PMCID: PMC6002955.https://pmc.ncbi.nlm.nih.gov/articles/pmid/29265742/
-
82
MYOPIA 2017 Sep: Agreement of Three Autorefractors in Children and Adolescents
Comparison of Refractive Measures of Three Autorefractors in Children and AdolescentsXiong S, Lv M, Zou H, Zhu J, Lu L, Zhang B, Deng J, Yao C, He X, Xu X. Comparison of Refractive Measures of Three Autorefractors in Children and Adolescents. Optom Vis Sci. 2017 Sep;94(9):894-902. doi: 10.1097/OPX.0000000000001113. PMID: 28816868; PMCID: PMC5571878.https://pmc.ncbi.nlm.nih.gov/articles/PMC5571878/pdf/opx-94-894.pdf
-
81
MYOPIA 2023 Nov: Aspherical Lenslets Preserve Choroidal Thickness in Myopic Children
Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 2-year randomised clinical trialHuang Y, Li X, Wu J, Huo J, Zhou F, Zhang J, Yang A, Spiegel DP, Chen H, Bao J. Effect of spectacle lenses with aspherical lenslets on choroidal thickness in myopic children: a 2-year randomised clinical trial. Br J Ophthalmol. 2023 Nov 22;107(12):1806-1811. doi: 10.1136/bjo-2022-321815. PMID: 36167484; PMCID: PMC10715521.https://pmc.ncbi.nlm.nih.gov/articles/PMC10715521/pdf/bjo-2022-321815.pdf
-
80
Axial length growth and the risk of developing myopia in European children
Axial length growth and the risk of developingmyopia in European children
-
79
Wavelength Effects on Axial Length and Choroidal Thickness
Wavelength Effects on Axial Length and Choroidal Thickness
-
78
MYOPIA 2025: Highly Aspherical Lenslets Influence Choroidal Thickness and Axial Length
The Influence of Highly Aspherical Lenslets on Choroidal Thickness and Axial LengthPaulasto, L.; Carré, C.; Loertscher, M. The Influence of Highly Aspherical Lenslets on Choroidal Thickness and Axial Length. J. Clin. Med. 2025, 14, 7059. https://doi.org/10.3390/jcm14197059https://www.mdpi.com/2077-0383/14/19/7059
-
77
MYOPIA 2008 JUL: Diurnal Rhythms of Ocular Biometrics and Intraocular Pressure
Diurnal variation of axial length, intraocular pressure, and anterior eye biometricsRead SA, Collins MJ, Iskander DR. Diurnal variation of axial length, intraocular pressure, and anterior eye biometrics. Invest Ophthalmol Vis Sci. 2008 Jul;49(7):2911-8. doi: 10.1167/iovs.08-1833. Epub 2008 Mar 24. PMID: 18362106.https://iovs.arvojournals.org/article.aspx?doi=10.1167/iovs.08-1833
-
76
MYOPIA 2023 FEB: MYAH and Myopia Master Reliability: Observer Experience and Ocular Parameters
The Repeatability and Agreement of Ocular Parameters Measured with the MYAH and Myopia Master Devices between Expert and Non-Expert PractitionersOrtiz-Toquero S, Sanchez I, Gurrea C, Recio A, Balsa D, Martin R. The Repeatability and Agreement of Ocular Parameters Measured with the MYAH and Myopia Master Devices between Expert and Non-Expert Practitioners. Life (Basel). 2024 Mar 19;14(3):407. doi: 10.3390/life14030407. PMID: 38541731; PMCID: PMC10971393.https://pmc.ncbi.nlm.nih.gov/articles/pmid/38541731/
-
75
MYAH and Lenstar Biometer Agreement and Repeatability
MYAH and Lenstar Biometer Agreement and Repeatability
-
74
MYOPIA 2019 SEP: Ocular Biometry, Refractive Error, and Body Characteristics Associations
Ocular biometry characteristics and corneal astigmatisms in cataract surgery candidates at a tertiary care center in North-East Indiahttps://pmc.ncbi.nlm.nih.gov/articles/pmid/31436184/Natung T, Shullai W, Nongrum B, Thangkhiew L, Baruah P, Phiamphu ML. Ocular biometry characteristics and corneal astigmatisms in cataract surgery candidates at a tertiary care center in North-East India. Indian J Ophthalmol. 2019 Sep;67(9):1417-1423. doi: 10.4103/ijo.IJO_1353_18. PMID: 31436184; PMCID: PMC6727703.
-
73
MYAH, Pentacam AXL, and IOLMaster 700 Agreement in Myopic Children
MYAH, Pentacam AXL, and IOLMaster 700 Agreement in Myopic Children
-
72
MYOPIA 2023 JUNE: Axial Length Accuracy
A Comparison of Optical Biometers Used in Children for Myopia Control
-
71
MYOPIA 2023 June: Optical Biometer Comparison for Pediatric Myopia Control
A Comparison of Optical Biometers Used in Children for Myopia ControlMattern AI, Neller K, Devenijn M, Schwahn H, Langenbucher A, Seitz B, Kaymak H. A Comparison of Optical Biometers Used in Children for Myopia Control. Klin Monbl Augenheilkd. 2023 Nov;240(11):1306-1313. doi: 10.1055/a-2117-9335. Epub 2023 Jun 26. PMID: 37364606; PMCID: PMC10651350.https://pmc.ncbi.nlm.nih.gov/articles/pmid/37364606/
-
70
DRYEYE 2025: TFOS DEWS III Management and Therapy Report
TFOS DEWS III Management and Therapy ReportLyndon Jones, Jennifer P. Craig, Maria Markoulli, Paul Karpecki, Esen K. Akpek, Sayan Basu, Etty Bitton, Wei Chen, Deepinder K. Dhaliwal, Murat Dogru, José Alvaro P. Gomes, Miranda Koehler, Jodhbir S. Mehta, Victor L Perez, Fiona Stapleton, David A. Sullivan, Joseph Tauber, Louis Tong, Sònia Travé-Huarte, James S. Wolffsohn, Monica Alves, Christophe Baudouin, Laura Downie, Giuseppe Giannaccare, Jutta Horwath-Winter, Zuguo Liu, Shizuka Koh, Messmer Elisabeth, Ernesto Otero, Edoardo Villani, Stephanie Watson, Kyung Chul Yoon,TFOS DEWS III Management and Therapy Report, American Journal of Ophthalmology, 2025,https://www.sciencedirect.com/science/article/pii/S0002939425002740/pdfft?md5=75a0b0f013a754577c84437c57c2567d&pid=1-s2.0-S0002939425002740-main.pdf
-
69
DRYEYE 2025: TFOS DEWS III: Dry Eye Diagnostic Methodology
TFOS DEWS III Diagnostic MethodologyJames S. Wolffsohn, José Benítez-Del-Castillo, Denise Loya-Garcia, Takenori Inomata, Geetha Iyar, Lingyi Liang, Heiko Pult, Alfonso L. Sabater, Christopher E. Starr, Jelle Vehof, Michael TM Wang, Wei Chen, Jennifer P Craig, Murat Dogru, Victor L Perez Quinones, Fiona Stapleton, David A Sullivan, Lyndon Jones, Reiko Arita, Carlos Belmonte, Robin L Chalmers, Anat Galor, Arkasubhra Ghosh, Marc Labetoulle, Kelly K. Nichols, Andrew D. Pucker, Eduardo M. Rocha, Benjamin Sullivan, Piera Versura, Mark DP Willcox, TFOS DEWS III Diagnostic Methodology,NAmerican Journal of Ophthalmology, 2025,https://www.sciencedirect.com/science/article/pii/S0002939425002752/pdfft?md5=1cad0199c1feab5245b4e35dac7f25c0&pid=1-s2.0-S0002939425002752-main.pdf
-
68
DRYEYE 2025: TFOS DEWS III: A Digest on Dry Eye Disease
TFOS DEWS III Digest ReportFiona Stapleton, Pablo Argüeso, Penny Asbell, Dimitri Azar, Charles Bosworth, Wei Chen, Joseph Ciolino, Jennifer P. Craig, Juana Gallar, Anat Galor, José A.P. Gomes, Isabelle Jalbert, Ying Jie, Lyndon Jones, Kenji Konomi, Yang Liu, Jesus Merayo-Lloves, Fabiola R. Oliveira, Victor A. Perez Quinones, Eduardo M. Rocha, Benjamin D. Sullivan, David A. Sullivan, Jelle Vehof, Susan Vitale, Mark Willcox, James Wolffsohn, Murat Dogru, TFOS DEWS III Digest Report, American Journal of Ophthalmology, 2025https://www.sciencedirect.com/science/article/pii/S0002939425002764/pdfft?md5=37bf657d9472fd8ae92649786db3320d&pid=1-s2.0-S0002939425002764-main.pdf
-
67
MYOPIA 2025 June: Myopia Control Lenses: Contrast Theory Versus Blur Theory
Diffusion Optics Technology (DOT): A Myopia Control Spectacle Lens Based on Contrast TheoryNeitz J, Neitz M. Diffusion Optics Technology (DOT): A Myopia Control Spectacle Lens Based on Contrast Theory. Transl Vis Sci Technol. 2024 Oct 1;13(10):42. doi: 10.1167/tvst.13.10.42. PMID: 39476085; PMCID: PMC11534017.'https://pubmed.ncbi.nlm.nih.gov/39476085/Visual impact of diffusion optic technology lenses for myopia controlWolffsohn JS, Hill JS, Hunt C, Young G. Visual impact of diffusion optic technology lenses for myopia control. Ophthalmic Physiol Opt. 2024 Nov;44(7):1398-1406. doi: 10.1111/opo.13386. Epub 2024 Sep 3. PMID: 39225035.https://onlinelibrary.wiley.com/doi/10.1111/opo.13386
-
66
MYOPIA 2025 June: Myopia: Genetics, Environment, Prediction, and Intervention
Perspectives on Genetic and Environmental Factors in Myopia, Its Prediction, and the Future Direction of ResearchKatie M. Williams, Christopher J. Hammond; Perspectives on Genetic and Environmental Factors in Myopia, Its Prediction, and the Future Direction of Research. Invest. Ophthalmol. Vis. Sci. 2025;66(7):4. https://doi.org/10.1167/iovs.66.7.4.https://iovs.arvojournals.org/article.aspx?articleid=2803081
-
65
MYOPIA 2025 June: Visual Diet and Myopia: Optical and Structural Insights
Optical and Visual Diet in MyopiaSusana Marcos; Optical and Visual Diet in Myopia. Invest. Ophthalmol. Vis. Sci. 2025;66(7):3. https://doi.org/10.1167/iovs.66.7.3.https://iovs.arvojournals.org/article.aspx?articleid=2803082
-
64
MYOPIA 2023: High Myopia in Young Children: Diagnosis and Management
IMI—Management and Investigation of High Myopia in Infants and Young ChildrenIan Flitcroft, John Ainsworth, Audrey Chia, Susan Cotter, Elise Harb, Zi-Bing Jin, Caroline C. W. Klaver, Anthony T. Moore, Ken K. Nischal, Kyoko Ohno-Matsui, Evelyn A. Paysse, Michael X. Repka, Irina Y. Smirnova, Martin Snead, Virginie J. M. Verhoeven, Pavan K. Verkicharla; IMI—Management and Investigation of High Myopia in Infants and Young Children. Invest. Ophthalmol. Vis. Sci. 2023;64(6):3. https://doi.org/10.1167/iovs.64.6.3.https://iovs.arvojournals.org/article.aspx?articleid=2785576
-
63
MYOPIA 2025 June: Part 2 Childhood Myopia: Treatments, Mechanisms, and Emerging Options
Childhood Myopia Part II: Treatment Mechanisms, Emerging Options, and Considerationshttps://iovs.arvojournals.org/article.aspx?articleid=2803078
-
62
MYOPIA 2025 June: Part 1 Childhood Myopia: Treatments and Efficacy
Childhood Myopia Part I: Contemporary Treatment OptionsSafal Khanal, Erin S. Tomiyama, Síofra C. Harrington; Childhood Myopia Part I: Contemporary Treatment Options. Invest. Ophthalmol. Vis. Sci.2025;66(7):6. https://doi.org/10.1167/iovs.66.7.6.https://iovs.arvojournals.org/article.aspx?articleid=2803079
-
61
MYOPIA 2023: Adult Myopia: Onset and Progression Research
IMI—Onset and Progression of Myopia in Young AdultsMark A. Bullimore, Samantha Sze-Yee Lee, Katrina L. Schmid, Jos J. Rozema, Nicolas Leveziel, Edward A. H. Mallen, Nina Jacobsen, Rafael Iribarren, Pavan K. Verkicharla, Jan Roelof Polling, Paul Chamberlain; IMI—Onset and Progression of Myopia in Young Adults. Invest. Ophthalmol. Vis. Sci.2023;64(6):2. https://doi.org/10.1167/iovs.64.6.2.https://iovs.arvojournals.org/article.aspx?articleid=2785578https://iovs.arvojournals.org/article.aspx?articleid=2785578
-
60
RETINA 2025 Mar: Distinguishing Macular Atrophy: An Australian Clinical Audit
Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in AustraliaMarkakis, D., Britten-Jones, A.C., Guymer, R.H. et al. Retrospective audit reviewing accuracy of clinical diagnosis of geographic atrophy in a single centre private tertiary retinal practice in Australia. Sci Rep 15, 8528 (2025). https://doi.org/10.1038/s41598-025-90516-zhttps://www.nature.com/articles/s41598-025-90516-z.pdf
-
59
MYOPIA 2025 June: Myopia: Correction, Control, and Management Defined
Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended UsageIan Flitcroft, Mark A. Bullimore, Kate L. Gifford, Jost B. Jonas, Deborah Jones, Lyndon W. Jones, Pauline Kang, Serge Resnikoff, Jeffrey Walline, Christine F. Wildsoet, On behalf of the International Myopia Institute (IMI); Myopia Correction, Myopia Control and Myopia Management: Definitions and Recommended Usage. Invest. Ophthalmol. Vis. Sci. 2025;66(6):41. https://doi.org/10.1167/iovs.66.6.41.https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvOTgxNDMvZWxpZmUtOTgxNDMtdjEucGRmP2Nhbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZXMub3JnL2FydGljbGVzLzk4MTQz/elife-98143-v1.pdf?_hash=fic3Uq7omxPpoBTFr66N5ML6vIHEKNQ2g4PjkRrwRLQ%3D
-
58
LOWVISION 2025 May: Visual Cortex Excitation-Inhibition Balance After Sight Restoration
Altered visual cortex excitatory/inhibitory ratio following transient congenital visual deprivation in humansPant R, Pitchaimuthu K, Ossandón JP, Shareef I, Lingareddy S, Finsterbusch J, Kekunnaya R, Röder B. Altered visual cortex excitatory/inhibitory ratio following transient congenital visual deprivation in humans. Elife. 2025 May 16;13:RP98143. doi: 10.7554/eLife.98143. PMID: 40377962; PMCID: PMC12084009.https://elifesciences.org/download/aHR0cHM6Ly9jZG4uZWxpZmVzY2llbmNlcy5vcmcvYXJ0aWNsZXMvOTgxNDMvZWxpZmUtOTgxNDMtdjEucGRmP2Nhbm9uaWNhbFVyaT1odHRwczovL2VsaWZlc2NpZW5jZXMub3JnL2FydGljbGVzLzk4MTQz/elife-98143-v1.pdf?_hash=fic3Uq7omxPpoBTFr66N5ML6vIHEKNQ2g4PjkRrwRLQ%3D
-
57
MYOPIA Mar 2025: Myopic Defocus Effects on Retina and Choroid
Effect of Myopic Defocus on the Retina and Choroid and Its Interaction with Defocus Regions, Diurnal Rhythm, and AccommodationHuang Y, Zhang J, Li X, Chen H, Bao J. Effect of Myopic Defocus on the Retina and Choroid and Its Interaction with Defocus Regions, Diurnal Rhythm, and Accommodation. Ophthalmol Sci. 2025 Mar 21;5(5):100773. doi: 10.1016/j.xops.2025.100773. PMID: 40375873; PMCID: PMC12076711.https://www.ophthalmologyscience.org/action/showPdf?pii=S2666-9145%2825%2900071-5
-
56
RETINA Mar 2025: Macular Hole Microvascular Changes Post-Vitrectomy
Microvascular Changes in Full-Thickness Macular Hole Patients Before and After Vitrectomy: An Optical Coherence Tomography-Angiography StudyGórska A, Sirek S, Woszczek D, Leszczyński R. Microvascular Changes in Full-Thickness Macular Hole Patients Before and After Vitrectomy: An Optical Coherence Tomography-Angiography Study. Clin Pract. 2025 Mar 11;15(3):58. doi: 10.3390/clinpract15030058. PMID: 40136594; PMCID: PMC11941384.https://pmc.ncbi.nlm.nih.gov/articles/PMC11941384/pdf/clinpract-15-00058.pdf
-
55
MYOPIA May 2025: Atropine and DIMS Lens Combination for Myopia Control
Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropineGuemes-Villahoz N, Talavero González P, Porras-Ángel P, Bella-Gala R, Ruiz-Pomeda A, Martin-Garcia B, Hernandez-Garcia E, Gomez de Liaño N, Shah R, Garcia-Feijoo J, Gomez-de-Liaño R. Atropine and Spectacle lens Combination Treatment (ASPECT): 12-month results of a randomised controlled trial for myopia control using a combination of Defocus Incorporated Multiple Segments (DIMS) lenses and 0.025% atropine. Br J Ophthalmol. 2025 May 9:bjo-2024-326852. doi: 10.1136/bjo-2024-326852. Epub ahead of print. PMID: 40345841.https://bjo.bmj.com/content/bjophthalmol/early/2025/05/08/bjo-2024-326852.full.pdf
-
54
DRYEYE Apr 2025: Ocular Lubrication Reduces Migraine Severity in Dry Eye Patients
A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migrainehttps://www.optometrytimes.com/view/treating-ded-can-reduce-migraine-severity-according-to-studyMd Isa, Nur Amalina MOptom1,∗; Krishnan, Arun V. MD, PhD2,3; Zagami, Alessandro S. MD2,3; Tummanapalli, Shyam S. PhD1; Spira, Katherine MD2; Papas, Eric B. PhD, FAAO1; Tavakoli, Azadeh PhD1; Markoulli, Maria PhD, FAAO1. A randomized crossover trial: The impact of ocular lubrication on migraine severity in persons with dry eye disease and migraine. Optometry and Vision Science 102(4):p 183-188, April 2025. | DOI: 10.1097/OPX.0000000000002241
-
53
GENERAL Mar 2025: Computer vision syndrome: a comprehensive literature review
Computer Vision Syndrome: Causes, Prevention, and ManagementKahal F, Al Darra A, Torbey A. Computer vision syndrome: a comprehensive literature review. Future Sci OA. 2025 Dec;11(1):2476923. doi: 10.1080/20565623.2025.2476923. Epub 2025 Mar 8. PMID: 40055942; PMCID: PMC11901492.https://pmc.ncbi.nlm.nih.gov/articles/PMC11901492/pdf/IFSO_11_2476923.pdf
We're indexing this podcast's transcripts for the first time — this can take a minute or two. We'll show results as soon as they're ready.
No matches for "" in this podcast's transcripts.
No topics indexed yet for this podcast.
Loading reviews...
ABOUT THIS SHOW
This podcast provides an easy to listen summary of eye care topics from eye research studies. New Shows Tuesdays and Thursdays.Listen to your AI experts Doctopus the Octometrist and Doc Otter Noh dive deep into the latest eye care research studies.This is an A.I. assisted podcast created and curated by Dr. Michael Nelson, OD FAAO.Our goal is to keep you up to date with the latest research on eye care topics.DISCLAIMER: We highly recommend you read each article yourself for accuracy.
HOSTED BY
Dr Michael Nelson, OD FAAO
Loading similar podcasts...